Latest Articles
Sur180 gets nearly $2.4M NIH grant to develop non-hormonal endo treatment - News is My Business
Sur180 gets nearly $2.4M NIH grant to develop non-hormonal endo treatment News is My Business
Published: July 9, 2025, 9:03 a.m.
Umbilical Endometriosis With Appendiceal Involvement: A Case Report.
Endometriosis is a common disease that affects women worldwide. While it is most commonly located in the pelvis, lesions may occur in other areas of the body. Concurrent umbilical and …
Published: July 7, 2025, midnight
Endometriosis Treatment Market Transforming Patient Care with Targeted Solutions - Precedence Research
Endometriosis Treatment Market Transforming Patient Care with Targeted Solutions Precedence Research
Published: July 3, 2025, 1:37 p.m.
Endometriosis Treatment Market Size to Hit USD 5.74 Billion by 2034 - Precedence Research
Endometriosis Treatment Market Size to Hit USD 5.74 Billion by 2034 Precedence Research
Published: July 3, 2025, 1:32 p.m.
Minilaparoscopic Versus Conventional Laparoscopic Hysterectomy: Insights from a Single-Center Retrospective Cohort Study with Legal Considerations.
Background and Objectives: We compared mini-laparoscopic and laparoscopic hysterectomy in terms of surgery duration, postoperative pain, conversion rate, blood loss, postoperative complications (Clavien-Dindo classification), and the length of hospital stay. …
Published: July 3, 2025, midnight
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country - Express Pharma
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country Express Pharma
Published: July 2, 2025, 7 a.m.
Exploring the Immune System's Role in Endometriosis: Insights Into Pathogenesis, Pain, and Treatment - Cureus
Exploring the Immune System's Role in Endometriosis: Insights Into Pathogenesis, Pain, and Treatment Cureus
Published: July 1, 2025, 10:11 p.m.
AstraZeneca's India Arm Receives Nod For Imfinzi Indication To Treat Endometrial Cancer - Republic World
AstraZeneca's India Arm Receives Nod For Imfinzi Indication To Treat Endometrial Cancer Republic World
Published: July 1, 2025, 2:59 p.m.
#AstraZeneca India gets #CDSCO nod for new Imfinzi indication to treat endometrial cancer - LinkedIn
#AstraZeneca India gets #CDSCO nod for new Imfinzi indication to treat endometrial cancer LinkedIn
Published: July 1, 2025, 2:26 p.m.
AstraZeneca India gets CDSCO nod for new Imfinzi indication to treat endometrial cancer - CNBC TV18
AstraZeneca India gets CDSCO nod for new Imfinzi indication to treat endometrial cancer CNBC TV18
Published: July 1, 2025, 2:06 p.m.
Link copied to clipboard!